Influenza Diagnostics Market Regional Analysis

North America is dominating the Influenza Diagnostics market with the largest market share. The North American region dominated the diagnostic market in 2023 which was mainly due to the government's support for high-quality healthcare, increase in focus of influenza outbreak, and the high buying power. The U.S. was the largest revenue contributor to the North American market in 2023. This is mainly because the U.S. market is expected to grow due to the well-established healthcare infrastructure and increase in programs for influenza diagnostics. These factors are increasing the growth of the influenza diagnostics market in the North America region.   

The Asia Pacific is poised for substantial growth during the forecast period. This is due to the fact that in countries such as India and China, where there is increasing awareness of diseases and an increasing incidence of cancer & diabetes, there are also growth opportunities. Influenza is a major concern for the Chinese population and is the most lethal type of disease. Jiangsu, Zhejiang, Hunan, Shanghai, Guangdong, and Fujian provinces in China were most severely affected during the pandemic. The demand for diagnostic products is anticipated to rise as improving the country's disease containment efforts, such as enhanced surveillance and cancelling live poultry markets, take precedence.